We are live on ! Find out more
KURA icon

Kura Oncology
KURA

171 hedge funds and large institutions have $1.4B invested in Kura Oncology in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 66 increasing their positions, 50 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

110% more call options, than puts

Call options by funds: $4.73M | Put options by funds: $2.25M

32% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 50

5% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 20

0% more funds holding

Funds holding: 171 → 171 (0)

1.55% less ownership

Funds ownership: 103.59% → 102.04% (-1.6%)

28% less capital invested

Capital invested by funds: $1.94B → $1.4B (-$542M)

29% less funds holding in top 10

Funds holding in top 10: 7 → 5 (-2)

Holders
171
Holders Change
–
Holders Change %
0%
% of All Funds
2.98%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.09%
New
21
Increased
66
Reduced
50
Closed
20
Calls
$4.73M
Puts
$2.25M
Net Calls
+$2.48M
Net Calls Change
-$14.1M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$44.5M
2
SCM
Suvretta Capital Management
New York
+$23M
3
GPP
Great Point Partners
Connecticut
+$12.4M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$10.6M
5
State Street
State Street
Massachusetts
+$10.5M

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$39.7M
2
Citadel Advisors
Citadel Advisors
Florida
-$34.7M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$34.1M
4
RI
RTW Investments
New York
-$30.6M
5
EAM
Eventide Asset Management
Massachusetts
-$22.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
GTC
26
Ghost Tree Capital
New York
$14.6M +$2.48M +100,000 +17%
Two Sigma Advisers
27
Two Sigma Advisers
New York
$14.6M +$1.62M +65,300 +10%
HA
28
HHLR Advisors
Cayman Islands
$13.6M – – –
CC
29
Commodore Capital
New York
$13M +$2.48M +99,938 +19%
AG
30
Artal Group
Luxembourg
$12.5M – – –
VA
31
VR Adviser
New York
$12M – – –
Assenagon Asset Management
32
Assenagon Asset Management
Luxembourg
$11.1M +$10.3M +415,879 +352%
VC
33
Vivo Capital
California
$11M – – –
GPP
34
Great Point Partners
Connecticut
$10.4M +$12.4M +500,000 New
Charles Schwab
35
Charles Schwab
California
$9.4M +$185K +7,444 +2%
SI
36
Sofinnova Investments
California
$9.27M +$8.97M +361,208 +434%
AAA
37
Affinity Asset Advisors
New York
$8.86M +$1.49M +60,000 +16%
UBS AM
38
UBS AM
Illinois
$8.19M +$2.3M +92,687 +31%
Millennium Management
39
Millennium Management
New York
$8.17M +$1.66M +66,711 +21%
N
40
Nuveen
North Carolina
$7.8M +$2.09M +83,989 +29%
ACP
41
Acuta Capital Partners
California
$7.37M -$4.55M -183,422 -34%
Renaissance Technologies
42
Renaissance Technologies
New York
$6.3M +$7.5M +302,200 New
D.E. Shaw & Co
43
D.E. Shaw & Co
New York
$6.23M -$1.2M -48,180 -14%
Verition Fund Management
44
Verition Fund Management
Connecticut
$5.84M +$2.11M +85,001 +44%
TCM
45
Tekla Capital Management
Massachusetts
$5.7M – – –
WP
46
Woodline Partners
California
$5.58M +$6.65M +267,683 New
RCMNY
47
Rubric Capital Management (New York)
New York
$4.83M +$5.75M +231,481 New
SCM
48
Sio Capital Management
New York
$4.63M +$218K +8,792 +4%
Bank of New York Mellon
49
Bank of New York Mellon
New York
$4.56M -$1.98M -79,622 -27%
FCM
50
Farallon Capital Management
California
$4.17M -$4.97M -200,000 -50%
1
2
3 4 5

KURA Hedge Fund Activity: Q2 2021 in Review

171 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q2 2021, worth a combined $1.4B — down 28% from $1.94B a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new KURA positions and 20 closed out — a net gain of 1 holder — while 66 added to existing stakes and 50 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $44.5M. The largest seller was Victory Capital Management, cutting an estimated $39.7M.

  • 171 institutional investors held Kura Oncology (KURA) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $1.4B of Kura Oncology stock for Q2 2021, down 28% quarter-over-quarter.
  • 21 funds opened new Kura Oncology positions in Q2 2021 and 20 closed out, a net change of +1 holder.
  • The largest Kura Oncology buyer in Q2 2021 was Deerfield Management, an estimated $44.5M added.
  • The largest Kura Oncology seller in Q2 2021 was Victory Capital Management, an estimated $39.7M sold.

Based on aggregated 13F filings for Q2 2021.